VANCOUVER, BC, March 9, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS)
Mr. Dan Kriznic, director of Invictus MD Strategies Corp. (the “Issuer”), announces that on March 2, 2017, he was granted stock options (the “Options”) to purchase 1,000,000 common shares of the Issuer exercisable at a price of $1.75 per common share on or before March 2, 2022.
Prior to the grant of Options, Mr. Kriznic had ownership and control, directly and indirectly, of 2,308,204 common shares, 85,000 warrants and 1,555,000 stock options of the Issuer, representing approximately 6.07% of the issued and outstanding common shares of the Issuer on a non-diluted basis and approximately 9.96% of the issued and outstanding common shares of the Issuer when assuming exercise of all 85,000 warrants and 1,555,000 stock options held by Mr. Kriznic.
Read more “Invictus MD’s Chairman and CEO Granted Stock Options”
VANCOUVER, BC, March 7, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to report that Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD currently owns 82.5%, has generated $1.578 million in revenue for the 8 months ending February 28, 2017, with a gross margin of $807,846, representing a 51% gross margin compared to the same period in the prior year gross margin of $617,779, and a 39.6% margin. Future Harvest’s Holland Secret signature brand fertilizer for the cannabis sector grew by 26.5% to $137,389 in revenue during that period.
Chris Pearson, Chief Revenue Officer of Future Harvest commented that, “we provide specialty fertilizers and other supplies for hydroponics, the indoor method of growing crops favored by cannabis cultivators. We know there’s an even larger market out there; we’re squarely focused on what’s made our business successful: high-value crops.”
Read more “Invictus MD’s Future Harvest Achieves Increase In Gross Margin Resulting From Increased Fertilizer Sales In The Cannabis-Centric Space”
VANCOUVER, BC, March 2, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) reports that it has granted 1,250,000 incentive stock options to directors, officers and consultants of the Company. The stock options are exercisable for a period of five years at an exercise price of $1.75 per share. The options were granted under and are subject to the terms and conditions of the Company’s Stock Option Plan.
About Invictus MD Strategies Corp.
Invictus MD Strategies Corp. is focused on three main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the ACMPR; Fertilizer and Nutrients through Future Harvest Development Ltd.; and Cannabis Data and Delivery, with its wholly owned subsidiary Poda Technologies Ltd.
For more information, please visit www.invictus-md.com.
On Behalf of the Board,
Chairman & CEO
Vice President, Marketing & Communications
Vancouver, BC, March 2, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has closed its previously announced bought deal private placement (the “Offering”), with Canaccord Genuity Corp. and Eventus Capital Corp. (collectively, the “Underwriters”), including a portion of the over-allotment option, for aggregate gross proceeds of $16,218,065. A total of 9,829,130 units (the “Units”), including those pursuant to the exercise of the over-allotment option, were issued at a price of $1.65 per Unit.
Each Unit is comprised of one common share and one half of one common share purchase warrant (each whole common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share (a “Warrant Share”) until September 2, 2018 at an exercise price of $2.35 per Warrant Share. The Warrants are subject to an acceleration provision that allows the Company to give notice of an earlier expiry date if the Company’s daily volume weighted average share price on the Canadian Securities Exchange (or such other stock exchange the Company may be trading on) is greater than $3.75 for 10 consecutive trading days.
Read more “Invictus MD Closes $16,218,065 Bought Deal Private Placement”